Target intelligence / Profile preview

RNA, U2 small nuclear 52, pseudogene (RNU2-52P)

Target: RNU2-52P
Molecular classification: Other, Pseudogene

Overview

RNA, U2 small nuclear 52, pseudogene (RNU2-52P) is a pseudogene belonging to the U2 small nuclear RNA (snRNA) gene family[2][5][6]. U2 snRNAs are involved in the splicing of pre-messenger RNA as part of the spliceosome complex, but RNU2-52P itself does not encode a functional RNA product and is not known to play any direct biological role. There are no known disease associations or therapeutic interventions reported for this pseudogene[4][5][6]. Because it lacks a protein product or functional RNA, and is not a molecular target, it is not considered a drug target or biomarker for disease.

Other names: RNU2-52PU2 snRNA pseudogene 52RNA, U2 small nuclear 52, pseudogene

Beyond the preview

Go deeper on RNA, U2 small nuclear 52, pseudogene (RNU2-52P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U2 small nuclear 52, pseudogene (RNU2-52P).

Explore the full profile